Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Liepins Edgars

From Bioblast
(Redirected from Liepinsh E)


MiPsociety
News and Events        
BEC 2020.1 Mitochondrial physiology
       
MitoEAGLE
        Working Groups         Short-Term Scientific Missions         Management Committee         Members        
MitoGlobal
   


EU-logo.jpg

COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping


Liepins Edgars


MitoPedia topics: EAGLE 

COST: Member COST WG1: WG1 COST WG2: WG2


COST Mentor: Mentor

MC Member - Management Committee MitoEAGLE
Name Liepinsh Edgars, Dr.
Institution Laboratory of Pharmaceutical Pharmacology,

Latvian Institute of Organic Synthesis, LV

Address Aizkraukles Street 21, LV-1006
City Riga
State/Province
Country Latvia
Email [email protected]
Weblink
O2k-Network Lab LV Riga Liepins E


Labels:



Publications

Abstracts

 PublishedReference
Cecatto 2023 BPS2023 San Diego2023
Sabine Schmitt
Cecatto C, Schmitt Sabine, Cardoso L, Videja M, Dambrova M, Makrecka-Kuka M, Liepinsh E, Gnaiger E (2023) Contribution of fatty acid oxidation to respiratory control in brain mitochondria. 67th Annual Meeting of the Biophysical Society.
Dambrova 2022 Abstract Bioblast20228.2. «10+5»
Dambrova Maija
Dambrova Maija, Vilskersts R, Liepinsh E(2022) Mitochondrial metabolites acylcarnitines: therapeutic potential and drug targets. Bioblast 2022: BEC Inaugural Conference. In: https://doi.org/10.26124/bec:2022-0001
»MitoFit Preprint« »Watch the presentation«
Wuest 2019 MiPschool Coimbra2019
Rob Wüst
Altered mitochondrial metabolism in the diabetic heart.
Lemieux 2019b MiP20192019
Hélène Lemieux
Altered mitochondrial metabolism in the diabetic heart.
Dambrova 2018 MiP20182018
MiPsociety
L-Carnitine: from discovery to cardiometabolic risk markers.
Liepins 2018 MiP20182018
MiPsociety
Mitochondrial and extramitochondrial effects of long-chain acylcarnitines.
Kuka 2018 MiP20182018
MiPsociety
The discovery of methyl-GBB - acylcarnitine lowering as an effective strategy to treat cardiometabolic diseases.
Makarova 2018 MiP20182018
MiPsociety
Plasma concentrations of fatty acids and acylcarnitines as biomarkers for diagnosis of insulin resistance in adipose and muscle tissues.
Volska 2018 MiP20182018
Kristina Volska
The mechanisms of long-chain acylcarnitine accumulation during ischemia.
Makrecka-Kuka 2018 MiPschool Tromso E12018
Marina Makrecka-Kuka
Cardiac fatty acid oxidation: from in vitro to in vivo.
Makrecka-Kuka 2018 MiP20182018
Marina Makrecka-Kuka
Fatty acid oxidation in brain: from aging to ischemia and sepsis.
Makrecka-Kuka 2017 Abstract MITOEAGLE Barcelona2017
COST Action MITOEAGLE
Fatty acid oxidation evaluation in mitochondria.
Makrecka-Kuka 2017 MiP20172017
Marina Makrecka-Kruka
Heart, brain and kidneys: who will survive? Tissue-specific changes in mitochondrial function in the experimental model of endotoxemia.
Makrecka-Kuka 2016 Abstract MitoFit Science Camp 20162016Long-chain acylCoAs vs acylcarnitines in mitochondrial bioenergetics: from in vitro to in vivo.
Makrecka 2013 Abstract MiP20132013Makrecka-Kuka M, Volska K, Kuka J, Liepins E, Dambrova M (2013) The accumulation of long chain acyl-carnitines is a major cause of mitochondrial damage during ischemia. Mitochondr Physiol Network 18.08.


MitoEAGLE Feedback

We are mostly interested in two WG: (1) Since we are working mostly with heart and muscles, we are interested in WG 2 - MitoEAGLE data repository in muscle and other tissues. (2) WG 1 - Standard operating procedures and user requirement document: Protocols, terminology, documentation. Since we have an expertise in fatty acid metabolism, we are specially interested in experimental protocols for the evaluation of mitochondrial capacities regarding fatty acid metabolism. Of course our parts of the WG are also in our interest. - Marina Makrecka-Kuka, Edgars Liepins (2016).


Participated at